Medication info
Amorex Tablet 375 mg

Amorex Tablet 375 mg

Prescription medicationTabletOral
Ingredient · strength
Amoxicillin Hydrate›250mg / 1 tabletDilute Potassium Clavulanate›212.73mg / 1 tablet
Manufacturer / importer
CTC Bio, Co., Ltd.
Appearance
It is a white or almost white, oval-shaped film-coated tablet.
Packaging
80 tablets/box [(8 tablets/PTP×10)], 100 tablets/box [(10 tablets/PTP×10)]
Approval status
Active

MFDS item code 201603597 · Approved 2016.06.20 · Insurance code 669502010

Summary

Main use
Treatment of respiratory, genitourinary, skin, bone, and dental infections
Who takes it
Adults · Children
Adult dose
The dose of this drug should be determined based on the patient's age, body weight, renal function, and the severity of the infection. Administer at the start of a meal to minimize potential gastrointestinal intolerance. Absorption of amoxicillin/clavulanate is optimized when administered at the start of a meal. ○ Adults: Administer 250 mg/125 mg of amoxicillin/potassium clavulanate orally per dose 3 times daily, every 8 hours. For severe infections and respiratory tract infections, the dose may be increased to 500 mg/125 mg of amoxicillin/potassium clavulanate per dose. ○ In patients with renal impairment, adjust the dose appropriately according to creatinine clearance. - Adults: Dosage adjustments are based on the maximum recommended dose of amoxicillin. No dosage adjustment is necessary in patients with creatinine clearance (CrCl) of 30 mL/min or greater. 10 ~ 30 mL/min Administer 250mg/125mg of amoxicillin/potassium clavulanate per dose every 12 hours or 500mg/125mg of amoxicillin/potassium clavulanate per dose. 10 mL/min or less Administer 250mg/125mg of amoxicillin/potassium clavulanate per dose every 24 hours or 500mg/125mg of amoxicillin/potassium clavulanate per dose. Hemodialysis Administer 250mg/125mg or 500mg/125mg of amoxicillin/potassium clavulanate per dose every 24 hours, administer an additional dose during dialysis, and repeat the dose at the end of dialysis. (Because serum concentrations of both amoxicillin and clavulanic acid decrease)
Child dose
Children aged 12 years or older or weighing 40 kg or more: Administer 250 mg/125 mg of amoxicillin/potassium clavulanate per dose orally 3 times daily, every 8 hours. For severe infections and respiratory tract infections, the dose may be increased to 500 mg/125 mg of amoxicillin/potassium clavulanate per dose. Children: Reduce the dose in the same manner.

Ingredients

Manufacturer
CTC Bio, Co., Ltd.

Efficacy & effects

Treatment of respiratory, genitourinary, skin, bone, and dental infections

  • Acute and chronic bronchitis
  • lobar pneumonia
  • bronchial pneumonia
  • empyema
  • lung abscess
  • tonsillitis
  • sinusitis
  • otitis media
  • cystitis
  • urethritis
  • pyelonephritis
  • pelvic infection
View approved original text

This medicine is effective against various bacterial infections. It can be used to treat respiratory infections such as acute or chronic bronchitis, pneumonia, empyema, and lung abscess. It also helps in treating urinary infections such as cystitis, urethritis, and pyelonephritis, as well as sexually transmitted diseases like gonorrhea. It is effective against skin and bone infections such as furunculosis, abscesses, soft tissue infections, wound infections, and osteomyelitis. It is used in the treatment of dental infections and contributes to the relief of pain and inflammation. This drug is used to improve bacterial infections in various areas.

How to take

Adult dose

The dose of this drug should be determined based on the patient's age, body weight, renal function, and the severity of the infection. Administer at the start of a meal to minimize potential gastrointestinal intolerance. Absorption of amoxicillin/clavulanate is optimized when administered at the start of a meal. ○ Adults: Administer 250 mg/125 mg of amoxicillin/potassium clavulanate orally per dose 3 times daily, every 8 hours. For severe infections and respiratory tract infections, the dose may be increased to 500 mg/125 mg of amoxicillin/potassium clavulanate per dose. ○ In patients with renal impairment, adjust the dose appropriately according to creatinine clearance. - Adults: Dosage adjustments are based on the maximum recommended dose of amoxicillin. No dosage adjustment is necessary in patients with creatinine clearance (CrCl) of 30 mL/min or greater. 10 ~ 30 mL/min Administer 250mg/125mg of amoxicillin/potassium clavulanate per dose every 12 hours or 500mg/125mg of amoxicillin/potassium clavulanate per dose. 10 mL/min or less Administer 250mg/125mg of amoxicillin/potassium clavulanate per dose every 24 hours or 500mg/125mg of amoxicillin/potassium clavulanate per dose. Hemodialysis Administer 250mg/125mg or 500mg/125mg of amoxicillin/potassium clavulanate per dose every 24 hours, administer an additional dose during dialysis, and repeat the dose at the end of dialysis. (Because serum concentrations of both amoxicillin and clavulanic acid decrease)

Child dose

Children aged 12 years or older or weighing 40 kg or more: Administer 250 mg/125 mg of amoxicillin/potassium clavulanate per dose orally 3 times daily, every 8 hours. For severe infections and respiratory tract infections, the dose may be increased to 500 mg/125 mg of amoxicillin/potassium clavulanate per dose. Children: Reduce the dose in the same manner.

Precautions

This drug should not be administered to patients with a history of hypersensitivity to penicillins or cephalosporins as it is a beta-lactam antibiotic. Caution is required for patients with viral infections such as infectious mononucleosis and lymphocytic leukemia, as the risk of rash may increase. Patients with a history of liver dysfunction or jaundice due to this drug or penicillin should avoid use due to the risk of recurrence. Patients with impaired liver function or severe renal impairment may have increased drug levels, so dosing intervals should be adjusted or careful monitoring should be performed. Patients with allergies or gastrointestinal symptoms such as vomiting and diarrhea should also exercise caution when taking this drug. This drug may cause gastrointestinal adverse reactions such as diarrhea, abdominal pain, and vomiting, and in severe cases may lead to pseudomembranous colitis, so it is important to stop taking it immediately in case symptoms occur. Rarely, liver function abnormalities may appear, and regular liver function tests should be conducted for the elderly or during prolonged usage. Skin rashes, itching, and severe skin reactions such as Stevens-Johnson syndrome may occur, so immediate medical attention is required if symptoms develop. Blood-related adverse reactions such as transient leukopenia or anemia have been reported, so monitoring is necessary if abnormal symptoms occur. Rarely, neurological symptoms such as headache, dizziness, and seizures may occur, so immediate reporting is necessary if neurological symptoms arise. Patients with renal function issues may suffer kidney damage and require regular check-ups, with discontinuation of use if symptoms appear. This drug may affect the balance of intestinal bacteria, leading to candida infections or stomatitis, and treatment is necessary if such symptoms arise. There is a risk of bleeding due to vitamin K deficiency, so elderly patients or those at risk of vitamin deficiency should be cautious. This drug may interact with other medications, especially anticoagulants, probenecid, and allopurinol, so consultation with a specialist is necessary when used in combination. Use should be avoided during the first three months of pregnancy, and women who are pregnant or breastfeeding should carefully weigh the risks and benefits of using this drug. It is not recommended for children under 12 years of age or weighing less than 40 kg. Due to decreased physical function, elderly patients may experience adverse reactions more easily, so dosage and administration intervals should be adjusted and closely monitored. Some clinical test results, such as urine glucose tests, may be distorted while taking this medication, so it is important to inform the physician during examinations. In case of overdose, gastrointestinal symptoms, renal impairment, and allergic reactions may occur, and immediate discontinuation and appropriate treatment are necessary. This medication should be stored in a dry place below 25 degrees, and to prevent the occurrence of resistant bacteria during prolonged use, it is advisable to use it for the shortest duration necessary.

Side effects

  • Diarrhea
  • pseudomembranous colitis
  • dyspepsia
  • stomatitis
  • gastritis
  • glossitis
  • black hairy tongue
  • nausea
  • vomiting
  • loss of appetite
Show 74 more
  • abdominal pain
  • abdominal distension
  • constipation
  • colonic pain
  • hyperacidity
  • soft stool
  • dry mouth
  • acute pancreatitis
  • candidiasis
  • antibiotic-induced colitis
  • bloody stool
  • itching
  • erythema multiforme
  • mucocutaneous syndrome
  • toxic epidermal necrolysis
  • blistering dermatitis
  • acute generalized pustular dermatosis
  • eosinophilia
  • angioedema
  • anaphylaxis
  • serum sickness syndrome
  • hypersensitivity vasculitis
  • bronchospasm
  • dyspnea
  • laryngeal edema
  • anaphylactic shock
  • leukopenia
  • thrombocytopenia
  • hemolytic anemia
  • anemia
  • thrombocytopenic purpura
  • eosinophilia
  • leukemia
  • agranulocytosis
  • lymphopenia
  • thrombocytosis
  • bone marrow suppression
  • prolonged bleeding time
  • prolonged prothrombin time
  • vaginal itching
  • burning sensation
  • increased secretion
  • restlessness
  • anxiety
  • behavior changes
  • confusion
  • drowsiness
  • insomnia
  • hyperactivity
  • dizziness
  • headache
  • convulsions
  • antispasmodic
  • fever
  • aseptic meningitis
  • acute renal failure
  • interstitial nephritis
  • hematuria
  • crystalluria
  • symptoms of vitamin K deficiency
  • symptoms of vitamin B complex deficiency
  • linear IgA disease
  • dysgeusia
  • fatigue
  • dermatitis
  • oral edema
  • stomachache
  • fluid and electrolyte imbalance
  • rash
  • hyperactivity
  • drowsiness
  • renal failure
  • interstitial cerebral convulsions
  • hypersensitivity shock

Not everyone experiences these, and they can vary from person to person.

Storage

This drug is stored in a tightly sealed container to prevent moisture, and it is advisable to maintain a cool temperature between 1 to 25 degrees during storage. This preserves the drug's efficacy and prevents deterioration.

Appearance and packaging

Appearance

It is a white or almost white, oval-shaped film-coated tablet.

Package unit

80 tablets/box [(8 tablets/PTP×10)], 100 tablets/box [(10 tablets/PTP×10)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.